Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Aβ25-35 -induced neurotoxicity in human neuroblastoma cells
- PMID: 25677400
- DOI: 10.1002/jnr.23565
Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Aβ25-35 -induced neurotoxicity in human neuroblastoma cells
Abstract
Accumulating evidence points to roles for oxidative stress, amyloid beta (Aβ), and mitochondrial dysfunction in the pathogenesis of Alzheimer's disease (AD). In neurons, the base excision repair pathway is the predominant DNA repair (BER) pathway for repairing oxidized base lesions. Apurinic/apyrimidinic endonuclease 1 (APE1), a multifunctional enzyme with DNA repair and reduction-oxidation activities, has been shown to enhance neuronal survival after oxidative stress. This study seeks to determine 1) the effect of Aβ25-35 on reactive oxygen species (ROS)/reactive nitrogen species (RNS) levels, 2) the activities of respiratory complexes (I, III, and IV), 3) the role of APE1 by ectopic expression, and 4) the neuromodulatory role of ginkgolide B (GB; from the leaves of Ginkgo biloba). The pro-oxidant Aβ25-35 peptide treatment increased the levels of ROS/RNS in human neuroblastoma IMR-32 and SH-SY5Y cells, which were decreased after pretreatment with GB. Furthermore, the mitochondrial APE1 level was found to be decreased after treatment with Aβ25-35 up to 48 hr, and the level was increased significantly in cells pretreated with GB. The oxidative phosphorylation (OXPHOS; activities of complexes I, III, and IV) indicated that Aβ25-35 treatment decreased activities of complexes I and IV, and pretreatment with GB and ectopic APE1 expression enhanced these activities significantly compared with Aβ25-35 treatment. Our results indicate that ectopic expression of APE1 potentiates neuronal cells to overcome the oxidative damage caused by Aβ25-35 . In addition, GB has been shown to modulate the mitochondrial OXPHOS against Aβ25-35 -induced oxidative stress and also to regulate the levels of ROS/RNS in the presence of ectopic APE1. This study presents findings from a new point of view to improve therapeutic potential for AD via the synergistic neuroprotective role played by APE1 in combination with the phytochemical GB.
Keywords: APE1; Alzheimer's disease; Aβ25-35; OXPHOS; Ref-1; amyloid beta; ginkgolide B.
© 2015 Wiley Periodicals, Inc.
Similar articles
-
Phytochemical Ginkgolide B Attenuates Amyloid-β1-42 Induced Oxidative Damage and Altered Cellular Responses in Human Neuroblastoma SH-SY5Y Cells.J Alzheimers Dis. 2017;60(s1):S25-S40. doi: 10.3233/JAD-161086. J Alzheimers Dis. 2017. PMID: 28234255
-
Curcumin revitalizes Amyloid beta (25-35)-induced and organophosphate pesticides pestered neurotoxicity in SH-SY5Y and IMR-32 cells via activation of APE1 and Nrf2.Metab Brain Dis. 2017 Dec;32(6):2045-2061. doi: 10.1007/s11011-017-0093-2. Epub 2017 Aug 31. Metab Brain Dis. 2017. PMID: 28861684
-
Inhibition of beta-amyloid-induced neurotoxicity by pinocembrin through Nrf2/HO-1 pathway in SH-SY5Y cells.J Neurol Sci. 2016 Sep 15;368:223-30. doi: 10.1016/j.jns.2016.07.010. Epub 2016 Jul 11. J Neurol Sci. 2016. PMID: 27538638
-
Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein.Chonnam Med J. 2016 May;52(2):75-80. doi: 10.4068/cmj.2016.52.2.75. Epub 2016 May 20. Chonnam Med J. 2016. PMID: 27231670 Free PMC article. Review.
-
[Ginkgolide B: mechanisms of neurobiological effects, prospects for use in the therapy of Alzheimer's disease].Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(4):22-27. doi: 10.17116/jnevro202412404122. Zh Nevrol Psikhiatr Im S S Korsakova. 2024. PMID: 38676673 Review. Russian.
Cited by
-
Multi-Target Mechanisms of Phytochemicals in Alzheimer's Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation.J Pers Med. 2022 Sep 15;12(9):1515. doi: 10.3390/jpm12091515. J Pers Med. 2022. PMID: 36143299 Free PMC article. Review.
-
Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.Drug Discov Today. 2017 Feb;22(2):223-233. doi: 10.1016/j.drudis.2016.10.010. Epub 2016 Oct 27. Drug Discov Today. 2017. PMID: 27794478 Free PMC article. Review.
-
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.Neurotherapeutics. 2019 Jul;16(3):666-674. doi: 10.1007/s13311-019-00767-8. Neurotherapeutics. 2019. PMID: 31376068 Free PMC article. Review.
-
Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities.Front Aging Neurosci. 2018 Oct 23;10:284. doi: 10.3389/fnagi.2018.00284. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30405389 Free PMC article. Review.
-
Protective Effects and Mechanisms of Dendrobium nobile Lindl. Alkaloids on PC12 Cell Damage Induced by Aβ 25-35.Behav Neurol. 2021 Aug 16;2021:9990375. doi: 10.1155/2021/9990375. eCollection 2021. Behav Neurol. 2021. PMID: 34447483 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous